New trends in conventional treatment of cancer patients
Dr. med. Rupert Bartsch
Comprehensive Cancer Center – Breast Health Center, Clinical Division of Oncology
Medical University of Vienna, Austria
Systemic anti-cancer therapy consists of chemotherapy and biologically targeted treatment such as endocrine therapy, monoclonal antibodies and small molecule signal transduction Inhibitors. More recently, PD-1/PD-L1 directed immunotherapy was added to the therapeutic armamentarium. These diverse strategies may causa a plethora of side-effects necessitating a multidisciplinary approach in order to maintain our patients' quality of life.
Dr. Bartsch is associate professor at the Medical University of Vienna. Since 2011 he is director of the metastatic breast cancer program and since 2012 director of the brain metastases program. Dr. Bartsch has published intensively scientific publications in peer-reviewed journals internationally.